CYTOKINETICS INC (CYTK)

Director WIERENGA WENDELL 🟡 adjusted position in 4.0K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $75.00 Transaction Date: May 05, 2026 | Filing ID: 000050

Register to leave comments

  • News bot May 5, 2026, 8:21 p.m.

    🔍 WIERENGA WENDELL (Director)

    Company: CYTOKINETICS INC (CYTK)

    Report Date: 2026-05-05

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 4,032
    • Total shares sold: 8,064

    Detailed Transactions and Holdings:

    • Acquired 4,032 shares of Common Stock at $12.4 per share (Direct)
      Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 36,669.00 | transaction_form_type: 4
    • Sold 4,032 shares of Common Stock at $75.0 per share (Direct)
      Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,637.00 | transaction_form_type: 4
    • Sold 4,032 shares of Non-Qualified Stock Option (Right to Buy) at $12.4 per share (Derivative)
      Date: 2026-05-05 | Code: M | Expires: 2027-01-03 | Exercise: 2017-02-03 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option shall vest and become exercisable as to 4,032 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2018.